About Us

Rapidscan Pharma Solutions (RPS, Inc.) was formed in 2010 by leading members of the team that discovered and developed regadenoson, a new pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease. RPS, Inc. has licensed the rights to sell regadenoson in Europe and other select territories.

Business size

1-10 employees

Commercial presence